Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction.

It is interesting to note that the P value approaching significance is driven by 1 subject in the standard treatment group who became undetectable at 48 weeks.

also in 1,814 other papers

One participant in the intensive group developed severe transient neutropenia at 60 weeks (after primary endpoint), which was not believed to be related to study medication. Human Immunodeficiency Virus Plasma Viral Loads and CD4 Count Responses to Treatment There was a nonsignificant trend to more rapid decline in plasma viral load in the intensive treatment group (Figure 2 ).

also in 3,883 other papers